☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Kala Pharmaceuticals Reports the US FDA’s Acceptance of IND Application of KPI-012 for Persistent Corneal Epithelial Defect
December 28, 2022
Insights+: EMA Marketing Authorization of New Drugs in November 2022
December 28, 2022
AstraZeneca’s Calquence (acalabrutinib) Receives the MHLW’s Approval for Treatment-Naïve Chronic Lymphocytic Leukaemia
December 28, 2022
Chong Kun Dang Pharmaceutical Reports P-III Trials of CKD-701 (biosimilar, ranibizumab) for the Treatment of Neovascular Age-Relat...
December 28, 2022
SpringWorks Reports the Completion of NDA Submission to the US FDA for Nirogacestat to Treat Desmoid Tumors
December 28, 2022
Polarean’s Xenoview (xenon Xe 129 hyperpolarized) Receives the US FDA’s Approval for Lung Ventilation
December 28, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions